Patents by Inventor D. Keith Gilding

D. Keith Gilding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4813966
    Abstract: A microporous biocompatible material is formed by preparing a segmented polyether urethane urea solution containing 25%.+-.1.5% solids dissolved in a solvent. The solution has sufficient viscosity to be preshaped and formed into the desired thickness of the finished article, then immediately immersed into a precipitation bath in which the solvent in the solution is miscible for a time interval sufficient to cause the solution to set up into an opaque elastomeric article. The article is immediately removed from the bath, any excess solvent extracted and then dried at a temperature on the order of 35.degree. C. to 70.degree. C. followed by heat treating by annealing for approximately sixty minutes at a temperature at 100.degree. C. to 130.degree. C. The void volume of the membrane solution is controlled to within the 50% to 80% range and the pore size from ca<0.1 to several mms.
    Type: Grant
    Filed: September 3, 1987
    Date of Patent: March 21, 1989
    Assignee: Matrix Medica, Inc.
    Inventors: D. Keith Gilding, Andrew M. Reed, Ian N. Askill, Stephen G. Briana
  • Patent number: 4704130
    Abstract: A microporous biocompatible material is formed by preparing a segmented polyether urethane urea solution containing 25%.+-.1.5% solids dissolved in a solvent. The solution has sufficient viscosity to be preshaped and formed into the desired thickness of the finished article, then immediately immersed into a precipitation bath in which the solvent in the solution is miscible for a time interval sufficient to cause the solution to set up into an opaque elastomeric article. The article is immediately removed from the bath, any excess solvent extracted and then dried at a temperature on the order of 35.degree. C. to 70.degree. C. followed by heat treating by annealing for approximately sixty minutes at a temperature at 100.degree. C. to 130.degree. C. The void volume of the membrane solution is controlled to within the 50% to 80% range and the pore size from ca <0.1 to several mms.
    Type: Grant
    Filed: October 18, 1985
    Date of Patent: November 3, 1987
    Assignee: Mitral Medical, International, Inc.
    Inventors: D. Keith Gilding, Andrew M. Reed, Ian N. Askill, Stephen G. Briana